|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 12164 |
FusionGeneSummary for ETV3_SEC22B |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ETV3_SEC22B | Fusion gene ID: 12164 | Hgene | Tgene | Gene symbol | ETV3 | SEC22B | Gene ID | 2117 | 9554 |
| Gene name | ETS variant 3 | SEC22 homolog B, vesicle trafficking protein (gene/pseudogene) | |
| Synonyms | METS|PE-1|PE1 | ERS-24|SEC22L1 | |
| Cytomap | 1q23.1 | 1p12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | ETS translocation variant 3ETS domain transcriptional repressor PE1ets variant gene 3, ETS family transcriptional repressormitogenic Ets transcriptional suppressor | vesicle-trafficking protein SEC22bER-Golgi SNARE of 24 kDaSEC22 vesicle trafficking protein homolog BSEC22 vesicle trafficking protein-like 1 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P41162 | ||
| Ensembl transtripts involved in fusion gene | ENST00000368192, ENST00000326786, ENST00000460850, | ENST00000453618, | |
| Fusion gene scores | * DoF score | 3 X 2 X 2=12 | 2 X 4 X 4=32 |
| # samples | 3 | 4 | |
| ** MAII score | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: ETV3 [Title/Abstract] AND SEC22B [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | SKCM | TCGA-ER-A3EV-06A | ETV3 | chr1 | 157105263 | - | SEC22B | chr1 | 145109524 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-3UTR | ENST00000368192 | ENST00000453618 | ETV3 | chr1 | 157105263 | - | SEC22B | chr1 | 145109524 | - |
| 5CDS-3UTR | ENST00000326786 | ENST00000453618 | ETV3 | chr1 | 157105263 | - | SEC22B | chr1 | 145109524 | - |
| intron-3UTR | ENST00000460850 | ENST00000453618 | ETV3 | chr1 | 157105263 | - | SEC22B | chr1 | 145109524 | - |
Top |
FusionProtFeatures for ETV3_SEC22B |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ETV3 | SEC22B |
| Transcriptional repressor that contribute to growtharrest during terminal macrophage differentiation by repressingtarget genes involved in Ras-dependent proliferation. RepressesMMP1 promoter activity. {ECO:0000269|PubMed:12007404}. | Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ETV3_SEC22B |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ETV3_SEC22B |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ETV3 | APP, MYC, SOX2, WHSC1L1, MLST8, ANTXR1, TSSC1, OLFM4, EWSR1, XPO1, PCDHB11, CSN1S1, PROZ | SEC22B | STX18, STX5, GOSR1, ELAVL1, S100A16, TMED10, SEPT11, TST, TCOF1, UBE2M, STIM1, TMED9, SUCLA2, ZYX, SMARCA2, SEPT9, VAMP2, SART1, UBXN1, MPST, SERPINH1, CPS1, TMEM189, XRCC1, VAPB, TMEM9, SUCLG2, SIN3A, TACO1, VPS29, TIMM9, VCP, FN1, UBL4A, ADRB2, ATP4A, B3GAT3, RPA1, RPA2, RPA3, CUL7, OBSL1, CCDC8, RNF2, DERL1, UBAC2, STX1A, TCTN2, TCTN3, TMEM17, TMEM216, CREB3, ATP6AP2, ATL3, GOLT1B, CENPO, MCM2, USE1, SCFD2, NBAS, RINT1, BNIP1, BET1, GOSR2, KIAA1033, STX8, NAPA, UGT8, SNAP47, VTI1B, NAPG, C19orf25, ZW10, STX7, STX6, KIAA1467, SCFD1, STX10, STX12, SLC39A3, PDHA1, SDHA, TRIM25, LMNA |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ETV3_SEC22B |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ETV3_SEC22B |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|